Urology Times presents Case-Based Peer Perspectives. In each video, expert physicians provide insight on managing urology-based patient cases that highlight the use of novel agents in clinical practice.
A 74-Year-Old Man with Metastatic Castration-Resistant Prostate Cancer (mCRPC) and A 62-Year-Old Man with High-Risk Localized Prostate Cancer
Navigating Treatment Decisions in Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)
Optimizing Sequential Therapy in Metastatic Castration-Resistant Prostate Cancer (mCRPC) with Bone-Predominant Disease
A 70-Year-Old Man Diagnosed With PSMA-Positive mCRPC
Case-Based Peer Perspectives: A 65-Year-Old Man Diagnosed with PSMA-positive mCRPC
A 72-Year-Old Man with Metastatic Urothelial Carcinoma and a 76-Year-Old Man with Locally Advanced, Resectable Urothelial Carcinoma
A 66-Year-Old-Man with Prostate Cancer and a 78-Year-Old Man with Metastatic Prostate Cancer
A 67-Year-Old-Man with Metastatic Prostate Cancer
A 60-Year-Old Woman With Muscle-Invasive Bladder Cancer and a 77-Year-Old Man With Muscle-Invasive Bladder Cancer
A 65-Year-Old Man with Prostate Cancer and a 77-Year-Old Man with Prostate Cancer
A 74-Year-Old-Man with Metastatic Prostate Cancer
A 66-Year-Old-Man with Metastatic Prostate Cancer
A 60-Year-Old Man with Prostate Cancer
A 64-Year-Old-Man with Metastatic Prostate Cancer
A 64-Year-Old Man with Elevated PSA Levels
A 75-Year-Old Woman with High-Risk Muscle Invasive Bladder Cancer
FDA news recap in urology for Q2 2025
da Vinci 5 Surgical System approved in Europe
RX Review: Implementing mitomycin for LG-IR-NMIBC in clinical practice
RX Review: TURBT vs chemoablation for low-grade, intermediate-risk NMIBC
Case Based Peer Perspectives